MEDQ - Medquist Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MEDQ - Medquist

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Nagaraju R. Arakotaram who wrote ()	11/19/1999 10:34:00 AM
From: Mark Peterson CPA	Read Replies (1) of 42

Had a wonderful run on MEDQ yesterday. This stock got unfairly slammed as a result of newsletter reporting alledged accounting improprieties: the application of the purchase method of accounting (instead of pooling of interests) to overstate their YoY and QoQ growth rates. Pure hogwash. Bought more of this stock at 22 - 23 1/2 yesterday and again in pre-market at 26 1/4 today. This ought to be a $30 stock yesterday! GS has already stepped in and defended the stock, upgrading it from a Buy to its Recommended list. The company (MEDQ)will probably have a thing or two to say about the contents of that misleading report. And then, we'll hear the rest of the story... Look for the stock to approach $34-$38 by year end. JMO, Mark A. Peterson Mark

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next